The American Enterprise Institute, a conservative think tank, holds a panel discussion: “Is the cure worth the cost? The debate over the price of specialty drugs.”
Panelists, including several AEI fellows as well as representatives from Amgen and Memorial Sloan Kettering Cancer Center, will discuss who should finance these important advancements and how.
Participants can RSVP to attend the event starting at 9 a.m. at AEI’s Washington, DC, office, or watch online.